IDB 1056

Drug Profile

IDB 1056

Alternative Names: Delphinidin chloride

Latest Information Update: 22 Aug 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Inverni della Beffa
  • Developer Indena; Inverni della Beffa
  • Class Antihyperglycaemics; Small molecules; Vascular disorder therapies; Vasodilators
  • Mechanism of Action Cell membrane permeability inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetic angiopathies; Varicose veins; Venous insufficiency

Most Recent Events

  • 31 Aug 1999 No-Development-Reported for Varicose veins in Italy (Unknown route)
  • 31 Aug 1999 No-Development-Reported for Venous insufficiency in Italy (Unknown route)
  • 14 Jul 1998 No-Development-Reported for Diabetic angiopathies in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top